ReviewInternational journal of molecular sciences2023

Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons.

Alisa Gisina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.